Full Product Details
Author: Yui-Wing Francis Lam (Professor of Pharmacology, Minnie Stevens Piper Professor, James O'Burke Endowed Centennial Fellow in Pharmacy, University of Texas Health Science Center, San Antonio, TX, USA) ,
Scott R. Stuart, MD (Associate Professor, Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, NY, USA)
Publisher: Elsevier Science Publishing Co Inc
Imprint: Academic Press Inc
Edition: 2nd edition
ISBN: 9780128126264
ISBN 10: 0128126264
Pages: 544
Publication Date: 05 December 2018
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Hardback
Publisher's Status: Forthcoming
Availability: Not yet available
This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release.
Author Information
Dr. Lam is Professor of Pharmacology at the University of Texas Health Science Center San Antonio (UTHSCSA). His editing experience included the first edition of Pharmacogenomics as well as being the lead editor of another published book entitled Herbal Supplements - Drug Interactions. Scientific and Regulatory Perspectives . He is also a co-author for a book chapter on pharmacogenetics in six consecutive editions of the textbook Pharmacotherapy: A Pathophysiologic Approach . Dr. Lam designed and continues to direct a graduate course Molecular and Pharmacological Basis of Therapeutics since 2002 for the UTHSCSA and the College of Pharmacy at the University of Texas at Austin. He has organized and participated in international and national symposia on topics related to personalized and molecular medicine, and is a scientific councilor for the Pacific Rim Association for Clinical Pharmacogenetics. Dr. Stuart Scott will take on the co-editor role for this second edition. Dr. Scott is an Assistant Professor in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, New York, where he oversees clinical pharmacogenetic testing as an ABMGG-certified Director of the Mount Sinai Genetic Testing Laboratory. His research interests include cardiovascular pharmacogenomics, multiethnic pharmacogenomic allele discovery, and long-read sequencing method development. He has co-authored Clinical Pharmacogenetics Implementation Consortium (CPIC) practice guidelines and is a member of other international genomics/pharmacogenomics consortia, and is a co-investigator of the Institute for Personalized Medicine (IPM) pharmacogenomics implementation program at Mount Sinai. He teaches pharmacogenetics to medical, graduate and genetic counseling students, clinical residents and fellows, and co-directs the comprehensive Translational Genomics graduate level course at Mount Sinai.
